CD47 and glioma: IHC analysis revealed that the three essential FAO enzymes CPT1A, CPT2, and ACAD9 were increased 86.96, 84.78, and 76.09% respectively in the recurrent gliomas, companied with 82.6% CD47 enhancement (Fig. 1a).